DPP4 and type 2 diabetes mellitus: Dipeptidyl peptidase-IV (DPP-IV) inhibitors, also known as gliptins, are a class of oral agents available since 2006 for the treatment of type 2 diabetes mellitus that inhibit the degradation of incretins [1, 2].